| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.33 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.084 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.3 |